CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 247640-247788 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1924","span":{"begin":0,"end":148},"obj":"Sentence"},{"id":"T7715","span":{"begin":0,"end":148},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, the study design for the doripenem ventilatorassociated pneumonia phase 3 trial includes an extended infusion regimen (0.5 g over 4 h)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T23","span":{"begin":0,"end":148},"obj":"Sentence"}],"text":"Furthermore, the study design for the doripenem ventilatorassociated pneumonia phase 3 trial includes an extended infusion regimen (0.5 g over 4 h)."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T242","span":{"begin":69,"end":78},"obj":"Phenotype"}],"attributes":[{"id":"A242","pred":"hp_id","subj":"T242","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Furthermore, the study design for the doripenem ventilatorassociated pneumonia phase 3 trial includes an extended infusion regimen (0.5 g over 4 h)."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T893","span":{"begin":69,"end":78},"obj":"Disease"},{"id":"T96426","span":{"begin":69,"end":78},"obj":"Disease"}],"attributes":[{"id":"A893","pred":"mondo_id","subj":"T893","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A34567","pred":"mondo_id","subj":"T96426","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"Furthermore, the study design for the doripenem ventilatorassociated pneumonia phase 3 trial includes an extended infusion regimen (0.5 g over 4 h)."}